From launching your product to training your team

Remap Consulting is the pricing and market access launch partner to help you launch with confidence.

Launch implementation

Develop and implement a pricing and market access launch strategy for your product

Learn more

Price Optimization

Having the right pharma pricing strategy is essential for your product to optimize revenues.

Learn more

Price & Market Access Training

We aim to make the transfer of knowledge more flexible, effective, and engaging.

Learn more

We work with people who’re asking:

Optimal price
What is the optimal price for our product?
Right evidence
Do we have the right evidence to support price and access to launch?
Training people
Do we have the right capabilities to train people on market access?
Market access potential
What is the pricing and market access potential for BD opportunities?

Discover the latest insights

Reflecting on the Pricing & Market Access tre…
Our experts reflect on the trends that shaped the European pricing and market access landscape in 20…
Read more
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R…
We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re…
Read more
ISPOR 2022 Plenary Session 3 – Integrating Data
Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for …
Read more
ISPOR 2022 Plenary Session 1 – HTA and Regulation
Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA …
Read more
PMA Insights: Week 44
We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth …
Read more
A winter of discontent? European pharmaceutical so…
EUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t…
Read more
PMA Insights: Week 42
We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth …
Read more
UK Agencies join with International HTA Partners f…
A cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can…
Read more
How important is HTA when launching a biosimilar i…
The short answer to the question “how important is HTA when launching a biosimilar in the EU5?” …
Read more
ISPOR 2022: Does NICE’s Sta process effectively …
We investigate Single Technology Appraisals (STAs) conducted by the National Institute for Health an…
Read more